Susan Mitchell

Susan Mitchell

Susan Mitchell is Deputy Editor of The Sunday Business Post. A native of Dublin, Mitchell has won numerous awards for her coverage of Ireland’s healthcare system. Her stories have led to several national policy changes. Mitchell holds a BA from UCD and a postgraduate diploma in business studies from the UCD Michael Smurfit Graduate Business School.

Sláintecare team wanted to get out of ‘troubled’ Department of Health

Sláintecare team wanted to get out of ‘troubled’ Department of Health

The government’s health reform team asked to be moved out of the Department of Health, due to c...

HSE interim chief in running for €300k director general role

HSE interim chief in running for €300k director general role

The HSE’s interim chief Anne O’Connor is among those shortlisted for the director general job...

The unhealthy truth about Ireland’s drugs deficit

The unhealthy truth about Ireland’s drugs deficit

Irish patients have access to fewer new medicines than those in other EU countries – and they wait longer to get them

Sláintecare strategy: show us the money

Sláintecare strategy: show us the money

Two years after it was conceived as an idea, we have an action plan for reform of the health system. Many critics say this is too little too late, with suspiciously little detail on where the funding is to come from for the ten-year plan

Women-only professorships could exclude trans people

Women-only professorships could exclude trans people

A spokesperson for junior education minister Mary Mitchell O’Connor said 'no decision had been made' as to whether the positions would be open to transgender applicants

No GP at one in five primary care centres

No GP at one in five primary care centres

‘Shocking’ figures show little progress made in planned Sláintecare reform programme

Doctors will have to prescribe cheaper drugs under new plans

Doctors will have to prescribe cheaper drugs under new plans

Doctors will be forced to prescribe cheaper drugs under plans being drawn up by the medicines reg...

Price still isn’t right for Biogen’s blockbuster drug

Price still isn’t right for Biogen’s blockbuster drug

HSE says Spinraza drug for SMA sufferers would cost €38 million over five years, as pharma giant clocks up global annual sales of $1.72 billion

Skin Deep: the rise of cosmeceuticals

Skin Deep: the rise of cosmeceuticals

With skincare brands making ever more ‘scientific’ claims about the anti-ageing benefits of their products, where does the truth lie? Susan Mitchell investigates

HSE has ‘almost exhausted’ its 2019 funding for new drugs

HSE has ‘almost exhausted’ its 2019 funding for new drugs

Professor Michael Barry, who heads up the National Centre for Pharmacoeconomics (NCPE), was speaking after the HSE informed Biogen, manufacturer of Spinraza, it would not fund the drug

Blackrock Medical in sale and lease back bid for children’s hospital

Blackrock Medical in sale and lease back bid for children’s hospital

Under the proposal, which was made to finance minister Paschal Donohoe, Blackrock Medical said it was interested in purchasing the property and buildings. It said the HSE could then enter into a lease for a 25-50 year term

The silent majority of health betrayals

The silent majority of health betrayals

In all the noise surrounding the Children’s Hospital fiasco, a multitude of other broken promises have been swept under the carpet

Cosmetic botch-ups lead to surge in A&E visits

Cosmetic botch-ups lead to surge in A&E visits

Patients are presenting to emergency departments with complications from dermal fillers that can ...

Health refuses to say if Harris’s response about hospital costs was altered

Health refuses to say if Harris’s response about hospital costs was altered

The Department of Health has refused to clarify whether the office of the Minister for Health alt...

CervicalCheck bosses advised against free smear test offer

CervicalCheck bosses advised against free smear test offer

The former clinical director of CervicalCheck advised against offering women a free out-of-cycle ...